Targeted Molecular Treatments in Non-Small Cell Lung Cancer: A Clinical Guide for Oncologists

被引：24
|
作者：
Bui, Kim Tam [1 ]
Cooper, Wendy A. [2 ,3 ,4 ]
Kao, Steven [1 ,4 ]
Boyer, Michael [1 ,4 ]
机构：
[1] Chris OBrien Lifehouse, 119-143 Missenden Rd Camperdown, Camperdown, NSW 2050, Australia
[2] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia
[3] Western Sydney Univ, Sch Med, Sydney, NSW 2560, Australia
[4] Royal Prince Alfred Hosp, 50 Missenden Rd Camperdown, Camperdown, NSW 2050, Australia
来源：
JOURNAL OF CLINICAL MEDICINE | 2018年 / 7卷 / 08期
关键词：
personalized therapy; non-small cell; lung cancer; targeted therapy; mutation; rearrangement; RANDOMIZED PHASE-III; PLATINUM-BASED CHEMOTHERAPY; OPEN-LABEL; 1ST-LINE TREATMENT; DOUBLE-BLIND; MAINTENANCE THERAPY; EGFR MUTATIONS; SINGLE-ARM; CARBOPLATIN-PACLITAXEL; ACQUIRED-RESISTANCE;
D O I：
10.3390/jcm7080192
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Targeted molecular treatments have changed the way non-small cell lung cancer (NSCLC) is managed. Epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), v-raf murine sarcoma viral oncogene homolog B1 (BRAF), and c-ros oncogene 1 (ROS1) mutations are now used to guide specific anti-cancer therapies to improve patient outcomes. New targeted molecular treatments are constantly being developed and evaluated as a means to improve efficacy, overcome resistance, or minimise toxicity. This review article summarises the current evidence for the efficacy, resistance mechanisms, and safety of targeted molecular treatments against specific mutations in NSCLC.
引用
收藏
页数：18
相关论文
共 50 条
  • [31] Molecular Pathology of Primary Non-small Cell Lung Cancer
    Suster, David Ilan
    Mino-Kenudson, Mari
    ARCHIVES OF MEDICAL RESEARCH, 2020, 51 (08) : 784 - 798
  • [32] Molecular therapeutic targets in non-small cell lung cancer
    Sankar, Kamya
    Gadgeel, Shirish M.
    Qin, Angel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (08) : 647 - 661
  • [33] Updates in the molecular pathology of non-small cell lung cancer
    Paver, Elizabeth
    O'Toole, Sandra
    Cheng, Xin Min
    Mahar, Annabelle
    Cooper, Wendy A.
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2021, 38 (05) : 54 - 61
  • [34] Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing
    Dong, Jingsi
    Li, Bingjie
    Lin, Dan
    Zhou, Qinghua
    Huang, Depei
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [35] Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer
    Nagano, Tatsuya
    Tachihara, Motoko
    Nishimura, Yoshihiro
    CURRENT CANCER DRUG TARGETS, 2019, 19 (08) : 595 - 630
  • [36] Landmark Studies of Targeted Therapies for Advanced Non-Small Cell Lung Cancer: A Guide for Pulmonologists
    Costantini, Adrien
    Katsikas, Theodoros
    Bostantzoglou, Clementine
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2020, 16 (01) : 5 - 10
  • [37] Therapeutic impact of molecular diagnosis in metastatic non-small cell lung cancer: Targeted therapies in 2013
    Pecuchet, N.
    Bigot, F.
    Henni, M.
    Fabre, E.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2014, 70 (1-2) : 38 - 46
  • [38] Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer
    Crintea, Andreea
    Constantin, Anne-Marie
    Motofelea, Alexandru C.
    Crivii, Carmen-Bianca
    Velescu, Maria A.
    Coseriu, Razvan L.
    Ilyes, Tamas
    Craciun, Alexandra M.
    Silaghi, Ciprian N.
    JOURNAL OF FUNCTIONAL BIOMATERIALS, 2023, 14 (09)
  • [39] New Targeted Therapy for Non-Small Cell Lung Cancer
    Chung, Eun Ki
    Yong, Seung Hyun
    Lee, Eun Hye
    Kim, Eun Young
    Chang, Yoon Soo
    Lee, Sang Hoon
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2023, 86 (01) : 1 - 13
  • [40] Advances in Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Targeted Therapy
    Giustini, Nicholas P.
    Jeong, Ah-Reum
    Buturla, James
    Bazhenova, Lyudmila
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 223 - +
12345